Peptide library / Adipotide

Adipotide

Adipotide is an experimental vascular-targeting peptide conjugate designed to damage blood vessels supplying white adipose tissue and studied in animal models.

Peptide & blend guide

The short version

Why people discuss it
Discussed for experimental fat loss through fat-tissue vascular targeting; animal findings do not establish a human benefit or dose. Community interest does not establish benefit or a suitable treatment.
What it is
Adipotide is an experimental vascular-targeting peptide conjugate designed to damage blood vessels supplying white adipose tissue and studied in animal models.
Biggest caution
Animal weight and fat-mass findings do not establish human efficacy or safety. A vascular-targeting mechanism also makes casual transfer into a community regimen inappropriate.
Stack context
Related profiles reflect adjacent community topics or biological context. They do not establish combination benefit, compatibility or a validated regimen.

Dose and frequency reference

Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.

Source agreement describes reported practice, not clinical validation.

Subcutaneous injection

No verified reference
Amount
No established typical human dose
Frequency
Not established in humans
Duration / phase
No established human cycle

The previously displayed 0.5 mg/kg/day came from primate extrapolation, not a validated human regimen. A newer publisher reports 0.25–1 mg/day for 4–8 weeks without human dose-finding support. These incompatible claims do not establish a suitable human amount. Reference only; this does not establish safety, effectiveness or individual suitability.

Reference source · reviewed 2026-09-12
Compare reported schedules

Saved source material reviewed 2026-09-27. Multiple pages from one publisher count as one source family; agreement does not establish what most people use. SC means subcutaneous; IM intramuscular; IP intraperitoneal.

Evidence & sources · Community source profile

AxonRep synthesizes community discussion signals from its internal research corpus. Individual creator sources remain attributed to the synthesis; public reference sites used in the latest comparison are linked separately. The synthesis is not clinical evidence.

Back to the peptide library